259 related articles for article (PubMed ID: 31758923)
1. MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation.
Kugler N; Klein K; Zanger UM
Biochem Pharmacol; 2020 Jan; 171():113725. PubMed ID: 31758923
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9.
Rieger JK; Reutter S; Hofmann U; Schwab M; Zanger UM
Drug Metab Dispos; 2015 Jun; 43(6):884-8. PubMed ID: 25802328
[TBL] [Abstract][Full Text] [Related]
3. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
Velazquez MNR; Parween S; Udhane SS; Pandey AV
Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
[TBL] [Abstract][Full Text] [Related]
4. Diosbulbin B induced G
Yang R; Wei M; Yang F; Sheng Y; Ji L
Toxicol Appl Pharmacol; 2018 Oct; 357():1-9. PubMed ID: 30145177
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Sorafenib-Associated Druggable Targets on Differential Gene Expression and ceRNA Network in Hepatocellular Carcinoma.
Fu Z; Yang G; Wang T; Gao D; Lin D; Liu X
J Environ Pathol Toxicol Oncol; 2023; 42(4):47-60. PubMed ID: 37522567
[TBL] [Abstract][Full Text] [Related]
6. 3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction.
Järvinen E; Hammer HS; Pötz O; Ingelman-Sundberg M; Stage TB
Clin Pharmacol Ther; 2023 Jun; 113(6):1284-1294. PubMed ID: 36906857
[TBL] [Abstract][Full Text] [Related]
7. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
8. Multiple microRNAs regulate tacrolimus metabolism through CYP3A5.
Gu XQ; Tang D; Wan P; Qin T; Yang TH; Wu J; Ji H; Liu JC; Xue F; Tang YJ; Xia Q
Pharmacol Res; 2021 Feb; 164():105382. PubMed ID: 33348024
[TBL] [Abstract][Full Text] [Related]
9. Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: influence of nongenetic factors and association with gene expression.
Rieger JK; Klein K; Winter S; Zanger UM
Drug Metab Dispos; 2013 Oct; 41(10):1752-62. PubMed ID: 23733276
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity.
Gill P; Bhattacharyya S; McCullough S; Letzig L; Mishra PJ; Luo C; Dweep H; James L
Sci Rep; 2017 Sep; 7(1):12331. PubMed ID: 28951593
[TBL] [Abstract][Full Text] [Related]
11. Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis.
Vuppalanchi R; Liang T; Goswami CP; Nalamasu R; Li L; Jones D; Wei R; Liu W; Sarasani V; Janga SC; Chalasani N
PLoS One; 2013; 8(9):e74471. PubMed ID: 24058572
[TBL] [Abstract][Full Text] [Related]
12. Development of Caco-2 cells expressing four CYPs via a mammalian artificial chromosome.
Ohta Y; Kazuki K; Abe S; Oshimura M; Kobayashi K; Kazuki Y
BMC Biotechnol; 2020 Aug; 20(1):44. PubMed ID: 32819341
[TBL] [Abstract][Full Text] [Related]
13. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
[TBL] [Abstract][Full Text] [Related]
14. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
15. Effect of miR-433-3p and miR-883b-5p on murine CYP 3A family enzymes in AML12 cells.
Sugino Y; Kugawa F
Pharmazie; 2018 Sep; 73(9):519-525. PubMed ID: 30223935
[TBL] [Abstract][Full Text] [Related]
16. Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.
Yoo SE; Yi M; Kim WY; Cho SA; Lee SS; Lee SJ; Shin JG
Drug Metab Pharmacokinet; 2019 Jun; 34(3):201-208. PubMed ID: 30992242
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
18. The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.
Chen Y; Zeng L; Wang Y; Tolleson WH; Knox B; Chen S; Ren Z; Guo L; Mei N; Qian F; Huang K; Liu D; Tong W; Yu D; Ning B
Biochem Pharmacol; 2017 Dec; 145():178-191. PubMed ID: 28822783
[TBL] [Abstract][Full Text] [Related]
19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
